rs4149639

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001065.4(TNFRSF1A):​c.551+234A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0601 in 152,256 control chromosomes in the GnomAD database, including 596 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.060 ( 596 hom., cov: 31)

Consequence

TNFRSF1A
NM_001065.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.176

Publications

12 publications found
Variant links:
Genes affected
TNFRSF1A (HGNC:11916): (TNF receptor superfamily member 1A) This gene encodes a member of the TNF receptor superfamily of proteins. The encoded receptor is found in membrane-bound and soluble forms that interact with membrane-bound and soluble forms, respectively, of its ligand, tumor necrosis factor alpha. Binding of membrane-bound tumor necrosis factor alpha to the membrane-bound receptor induces receptor trimerization and activation, which plays a role in cell survival, apoptosis, and inflammation. Proteolytic processing of the encoded receptor results in release of the soluble form of the receptor, which can interact with free tumor necrosis factor alpha to inhibit inflammation. Mutations in this gene underlie tumor necrosis factor receptor-associated periodic syndrome (TRAPS), characterized by fever, abdominal pain and other features. Mutations in this gene may also be associated with multiple sclerosis in human patients. [provided by RefSeq, Sep 2016]
TNFRSF1A Gene-Disease associations (from GenCC):
  • TNF receptor 1-associated periodic fever syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Illumina, Laboratory for Molecular Medicine, Ambry Genetics, PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 12-6332835-T-C is Benign according to our data. Variant chr12-6332835-T-C is described in ClinVar as Benign. ClinVar VariationId is 677250.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.154 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001065.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNFRSF1A
NM_001065.4
MANE Select
c.551+234A>G
intron
N/ANP_001056.1P19438-1
TNFRSF1A
NM_001346091.2
c.227+234A>G
intron
N/ANP_001333020.1P19438-2
TNFRSF1A
NM_001346092.2
c.-27+234A>G
intron
N/ANP_001333021.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNFRSF1A
ENST00000162749.7
TSL:1 MANE Select
c.551+234A>G
intron
N/AENSP00000162749.2P19438-1
TNFRSF1A
ENST00000540022.5
TSL:1
c.422+234A>G
intron
N/AENSP00000438343.1F5H061
TNFRSF1A
ENST00000366159.9
TSL:1
n.585+234A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0601
AC:
9138
AN:
152138
Hom.:
598
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.157
Gnomad AMI
AF:
0.00987
Gnomad AMR
AF:
0.0802
Gnomad ASJ
AF:
0.0346
Gnomad EAS
AF:
0.0794
Gnomad SAS
AF:
0.0381
Gnomad FIN
AF:
0.00311
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.00770
Gnomad OTH
AF:
0.0569
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0601
AC:
9158
AN:
152256
Hom.:
596
Cov.:
31
AF XY:
0.0617
AC XY:
4596
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.157
AC:
6525
AN:
41524
American (AMR)
AF:
0.0801
AC:
1226
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0346
AC:
120
AN:
3470
East Asian (EAS)
AF:
0.0796
AC:
412
AN:
5178
South Asian (SAS)
AF:
0.0379
AC:
183
AN:
4828
European-Finnish (FIN)
AF:
0.00311
AC:
33
AN:
10622
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.00767
AC:
522
AN:
68016
Other (OTH)
AF:
0.0577
AC:
122
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
398
796
1193
1591
1989
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0290
Hom.:
302
Bravo
AF:
0.0682
Asia WGS
AF:
0.0790
AC:
272
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
2.2
DANN
Benign
0.44
PhyloP100
0.18
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4149639; hg19: chr12-6442001; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.